(Q36643404)

15 August 2017

Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas (English)

1 reference

15 August 2017

1 reference

1

I Ray-Coquard

0 references

Jean-Yves Blay

9

object named as

J Y Blay

0 references

author name string

H Ghesquière

2

1 reference

15 August 2017

T Bachelot

3

1 reference

15 August 2017

C Borg

4

1 reference

15 August 2017

P Biron

5

1 reference

15 August 2017

C Sebban

6

1 reference

15 August 2017

A LeCesne

7

1 reference

15 August 2017

F Chauvin

8

1 reference

15 August 2017

ELYPSE Study Group

10

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

85

1 reference

15 August 2017

6

1 reference

15 August 2017

816-822

1 reference

Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported

15 August 2017

start time

1 September 2001

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1054/bjoc.2001.2011

0 references

cites work

Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375083

A risk model for thrombocytopenia requiring platelet transfusion after cytotoxic chemotherapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375083

Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375083

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375083

Analysis of early and late deaths on RTOG non-small cell carcinoma of the lung trials: comparison with CALGB 8433.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375083

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375083

Current techniques of nutritional assessment.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375083

Causes of death in febrile granulocytopenic cancer patients receiving empiric antibiotic therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375083

Patients at risk of chemotherapy-associated toxicity in small cell lung cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375083

The role of infection in the morbidity and mortality of patients with head and neck cancer undergoing multimodality therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375083

Cancer chemotherapy in older adults. A tolerability perspective

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375083

Five-year cancer cure: relation to total amount of peripheral lymphocytes and neutrophils

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375083

An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375083

Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors

28 June 2018

1 reference

12 December 2020

Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: results of a multivariate analysis

1 reference

12 December 2020

Risk model for severe anemia requiring red blood cell transfusion after cytotoxic conventional chemotherapy regimens. The Elypse 1 Study Group

1 reference

12 December 2020

Spontaneous apoptosis of CD8+ T lymphocytes in peripheral blood of patients with advanced melanoma

1 reference

12 December 2020

Nutrition and the cancer problem

1 reference

12 December 2020

[Prognostic factors in the response of a first line chemotherapy in advanced breast cancer]

1 reference

12 December 2020

An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas

1 reference

12 December 2020

Fas ligand in human serum

1 reference

12 December 2020

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

1 reference

12 December 2020

Single agent versus combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: a meta-analysis of response, toxicity, and survival

1 reference

12 December 2020

Identifiers

DOI

10.1054/BJOC.2001.2011

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference

15 August 2017

PubMed publication ID

11556830

1 reference